Combivent Warnings and Precautions

Understanding Combivent warnings and precautions prior to starting the medication can help ensure a safe treatment process. These include telling your healthcare provider immediately if your breathing problems become worse during treatment and avoiding the drug if you allergic to any of the active or inactive components. Combivent warnings and precautions also apply to people who are allergic to soybeans, peanuts, or soy lecithin.

Combivent: What Should I Tell My Healthcare Provider?

In order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer, Combivent inhalers (in their original form) will not be available after July 2013 because they contain chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. A new formulation, Combivent Respimat, became available starting in October 2012. People using the old Combivent inhaler will need to get a new prescription in order to switch to the new Combivent Respimat inhaler.


You should talk with your healthcare provider prior to taking Combivent® (ipratropium and albuterol inhaler) if you have:
Also, let your healthcare provider know if you are:
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
Make sure to tell your healthcare provider about all of the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.

Combivent Inhaler Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.